Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Annette Dale-Perera, Farrukh Alam & Peter Barker. (2015) Opioid-dependence treatment in the era of recovery: insights from a UK survey of physicians, patients and out-of-treatment opioid users. Journal of Substance Use 20:5, pages 354-362.
Read now
Read now
Sebastian Trautmann & Hans-Ulrich Wittchen. (2012) Abstinence Orientation and Treatment Practice: An Analysis of German Settings Providing Opioid Maintenance Therapy. Substance Use & Misuse 47:1, pages 22-30.
Read now
Read now
Linn R. Gjersing, Linn R. Gjersing, Tony Butler, Linn R. Gjersing, Tony Butler, John R. M. Caplehorn, Linn R. Gjersing, Tony Butler, John R. M. Caplehorn, Josephine M. Belcher, Linn R. Gjersing, Tony Butler, John R. M. Caplehorn, Josephine M. Belcher, Richard Matthews, Linn R. Gjersing, Tony Butler, John R. M. Caplehorn, Josephine M. Belcher & Richard Matthews. (2007) Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff. Drug and Alcohol Review 26:5, pages 501-508.
Read now
Read now
Hege Kornør, Hege Kornør, Helge Waal, Hege Kornør, Helge Waal, Leiv Sandvik, Hege Kornør, Helge Waal & Leiv Sandvik. (2007) Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status. Drug and Alcohol Review 26:2, pages 135-141.
Read now
Read now
DeborahJ. Kayman, MarjorieF. Goldstein, Sherry Deren & Andrew Rosenblum. (2006) Predicting Treatment Retention with a Brief “Opinions About Methadone” Scale. Journal of Psychoactive Drugs 38:1, pages 93-100.
Read now
Read now
Giedrius Vanagas, Zilvinas Padaiga & Eugenijus Bagdonas. (2006) Cost-Utility Analysis of Methadone Maintenance Treatment: A Methodological Approach. Substance Use & Misuse 41:1, pages 87-101.
Read now
Read now
Hege Kornør & Helge Waal. (2005) From opioid maintenance to abstinence: a literature review. Drug and Alcohol Review 24:3, pages 267-274.
Read now
Read now
Siara Andrews, JamesL. Sorensen, Joseph Guydish, Kevin Delucchi & Brian Greenberg. (2005) Knowledge and Attitudes About Methadone Maintenance Among Staff Working in a Therapeutic Community. Journal of Maintenance in the Addictions 3:1, pages 47-59.
Read now
Read now
Lynn Jones, Janet Edge & Alix C. Love. (2005) The effect of educational intervention on pharmacists' attitudes to substance misusers. Journal of Substance Use 10:5, pages 285-292.
Read now
Read now
Jenny Keen & Philip Oliver. (2004) Commissioning pharmacological treatments for drug users: a brief review of the evidence base. Drugs: Education, Prevention and Policy 11:2, pages 149-156.
Read now
Read now
Shulamith
Lala Ashenberg Straussner & Evan Senreich. (2002) Educating social workers to work with individuals affected by substance use disorders. Substance Abuse 23:sup1, pages 319-340.
Read now
Read now
Yuet W. Cheung & James M. N. Ch'ien. (1999) Previous Participation in Outpatient Methadone Program and Residential Treatment Outcome: A Research Note from Hong Kong. Substance Use & Misuse 34:1, pages 103-118.
Read now
Read now
Sung-Yeon Kang, Stephen Magura, Peter Nwakeze & Sy Demsky. (1998) Counselor Attitudes in Methadone Maintenance. Journal of Maintenance in the Addictions 1:2, pages 41-58.
Read now
Read now
John R. M. Caplehorn, Diana M. Hartel & Les Irwig. (1997) Measuring and Comparing the Attitudes and Beliefs of Staff Working in New York Methadone Maintenance Clinics. Substance Use & Misuse 32:4, pages 399-413.
Read now
Read now
John R. M. Caplehorn, Les Irwig & John B. Saunders. (1996) Physicians' Attitudes and Retention of Patients in Their Methadone Maintenance Programs. Substance Use & Misuse 31:6, pages 663-677.
Read now
Read now
John R. M. Caplehorn, Les Irwig, John B. Saunders & B. Chir. (1996) Attitudes and Beliefs of Staff Working in Methadone Maintenance Clinics. Substance Use & Misuse 31:4, pages 437-452.
Read now
Read now
John R. M. Caplehorn & Michael W. Ross. (1995) Methadone Maintenance and the Likelihood of Risky Needle-Sharing. International Journal of the Addictions 30:6, pages 685-698.
Read now
Read now
Articles from other publishers (26)
Megan Buresh, Robert Stern & Darius Rastegar. (2021) Treatment of opioid use disorder in primary care. BMJ, pages n784.
Crossref
Crossref
Wilfried Kunstmann, Michael Specka, Norbert Wodarz & Norbert Scherbaum. (2020) Zusammenfassende Darstellung der wissenschaftlichen Grundlagen der
Richtlinie der Bundesärztekammer zur Durchführung der
substitutionsgestützten Behandlung
Opioidabhängiger. Das Gesundheitswesen 82:11, pages 915-919.
Crossref
Crossref
Anees Bahji, Breagh Cheng, Samantha Gray & Heather Stuart. (2020) Mortality Among People With Opioid Use Disorder: A Systematic Review and Meta-analysis. Journal of Addiction Medicine 14:4, pages e118-e132.
Crossref
Crossref
Anees Bahji, Bobby Yanagawa & Wiplove Lamba. (2020) Harm Reduction for Injection Drug Users with Infective Endocarditis: A Systematic Review. Canadian Journal of Addiction 11:2, pages 13-23.
Crossref
Crossref
A. Bahji, B. Cheng, S. Gray & H. Stuart. (2019) Reduction in mortality risk with opioid agonist therapy: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica 140:4, pages 313-339.
Crossref
Crossref
B. Andraka-Christou. 2016. Animal Models for Medications Screening to Treat Addiction. Animal Models for Medications Screening to Treat Addiction
15
38
.
Sheena G. Sullivan, Zunyou Wu, Keming Rou, Lin Pang, Wei Luo, Changhe Wang, Xiaobin Cao, Wenyuan Yin, Enwu Liu & Guodong Mi. (2015) Who uses methadone services in China? Monitoring the world's largest methadone programme. Addiction 110, pages 29-39.
Crossref
Crossref
Ed Day. (2012)
Commentary on
N
osyk
et al
. (2012): Detoxification from methadone maintenance therapy: how important is the exact technique that is used?
. Addiction 107:9, pages 1630-1631.
Crossref
Crossref
F. González-Saiz & T. García-Valderrama. (2012) Medida de la eficiencia técnica de programas de tratamiento con opiáceos: utilidad del modelo Data Envelopment Analysis (DEA). Trastornos Adictivos 14:3, pages 79-88.
Crossref
Crossref
F. González-Saiz. (2009) Escala de Adecuación de Dosis de Opiáceos (EADO): un nuevo instrumento para la evaluación clínica del ajuste de las dosis de metadona. Trastornos Adictivos 11:1, pages 24-34.
Crossref
Crossref
Karen I. Kroeker, Vincent G. Bain, Thomas Shaw-Stiffel, Tse-Ling Fong & Eric M. Yoshida. (2008) Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007. Liver International 28:9, pages 1250-1255.
Crossref
Crossref
Icro Maremmani, Pier Paolo Pani, Matteo Pacini & Giulio Perugi. (2007) Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. Journal of Substance Abuse Treatment 33:1, pages 91-98.
Crossref
Crossref
C. A. J. de Jong & P. B. L. M. Gottmer. 2006. Handboek psychopathologie deel 2. Handboek psychopathologie deel 2
213
246
.
Helge Waal & Hege Kornør. (2004) Abstinence-oriented therapies for opiate addicts. Current Opinion in Psychiatry 17:3, pages 169-174.
Crossref
Crossref
A. Uchtenhagen. 2003. Addiction Mechanisms, Phenomenology and Treatment. Addiction Mechanisms, Phenomenology and Treatment
33
60
.
Timothy P. Ellingstad, Linda C. Sobell, Mark B. Sobell & Pamela Planthara. (2002) Drug treatment outcome methodology (1993–1997). Addictive Behaviors 27:3, pages 319-330.
Crossref
Crossref
A. Uchtenhagen. 2001. Contemporary Psychiatry. Contemporary Psychiatry
2167
2184
.
A. Uchtenhagen. 2000. Erlebens- und Verhaltensstörungen, Abhängigkeit und Suizid. Erlebens- und Verhaltensstörungen, Abhängigkeit und Suizid
601
628
.
RALF GERLACH & JOHN R.M. CAPLEHORN. (2009) Attitudes and beliefs of doctors prescribing methadone to addicts in the Westfalen‐Lippe region of Germany. Drug and Alcohol Review 18:2, pages 163-170.
Crossref
Crossref
Marc Gelkopf, Avi Bleich, Rachel Hayward, Gershon Bodner & Miriam Adelson. (1999) Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug and Alcohol Dependence 55:1-2, pages 63-68.
Crossref
Crossref
Marnik G. Dekimpe, Linda M. Van de Gucht, Dominique M. Hanssens & Keiko I. Powers. (1998) Long-Run Abstinence After Narcotics Abuse: What Are the Odds?. Management Science 44:11-part-1, pages 1478-1492.
Crossref
Crossref
John R.M Caplehorn, Thomas S Lumley & Les Irwig. (1998) Staff attitudes and retention of patients in methadone maintenance programs. Drug and Alcohol Dependence 52:1, pages 57-61.
Crossref
Crossref
John R.M. Caplehorn, Thomas S. Lumley, Les Irwig & John B. Saunders. (1998) Changing attitudes and beliefs of staff working in methadone maintenance programs. Australian and New Zealand Journal of Public Health 22:4, pages 505-508.
Crossref
Crossref
D Simpson, R A Braithwaite, D R Jarvie, M J Stewart, S Walker, I W Watson & B Widdop. (2016) Screening for Drugs of Abuse (II): Cannabinoids, Lysergic Acid Diethylamide, Buprenorphine, Methadone, Barbiturates, Benzodiazepines and other Drugs. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 34:5, pages 460-510.
Crossref
Crossref
Patrick G. O'Connor & Jeffrey H. Samet. (1996) The substance-using human immunodeficiency virus patient: Approaches to outpatient management. The American Journal of Medicine 101:4, pages 435-444.
Crossref
Crossref
Barbara Teresa Andraka-Christou. (2016) Essay: Improving Drug Courts Through Medication-Assisted Treatment for Addiction. SSRN Electronic Journal.
Crossref
Crossref